4.5 Article

Use of psychotropic drugs during pregnancy and breast-feeding

Journal

ACTA PSYCHIATRICA SCANDINAVICA
Volume 132, Issue -, Pages 1-28

Publisher

WILEY
DOI: 10.1111/acps.12479

Keywords

psychotropic drugs; pregnancy; breast-feeding; clinical guidelines; recommendations

Categories

Funding

  1. Bristol-Myers Squibb
  2. Astra Zeneca
  3. Janssen Cilag
  4. Servier
  5. Otsuka Pharmaceuticals
  6. Eli Lilly

Ask authors/readers for more resources

ObjectiveTo write clinical guidelines for the use of psychotropic drugs during pregnancy and breast-feeding for daily practice in psychiatry, obstetrics and paediatrics. MethodAs we wanted a guideline with a high degree of consensus among health professionals treating pregnant women with a psychiatric disease, we asked the Danish Psychiatric Society, the Danish Society of Obstetrics and Gynecology, the Danish Paediatric Society and the Danish Society of Clinical Pharmacology to appoint members for the working group. A comprehensive review of the literature was hereafter conducted. ResultsSertraline and citalopram are first-line treatment among selective serotonin reuptake inhibitor for depression. It is recommended to use lithium for bipolar disorders if an overall assessment finds an indication for mood-stabilizing treatment during pregnancy. Lamotrigine can be used. Valproate and carbamazepin are contraindicated. Olanzapine, risperidone, quetiapine and clozapine can be used for bipolar disorders and schizophrenia. ConclusionIt is important that health professionals treating fertile women with a psychiatric disease discuss whether psychotropic drugs are needed during pregnancy and how it has to be administered.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available